Skip to content
Search

Latest Stories

Kamsons Pharmacy co-owner, Piyoosh Chotai, passes away aged 69

Piyoosh Chotai, co-owner of the pharmaceutical chain, Waremoss Limited, passed away on Saturday, Jan 18. He was 69.

Piyoosh is survived by his wife, Anna, and their two daughters – Sonal and Priya.


According to family friends, Piyoosh “passed away peacefully in the presence of his family and friends in Croydon hospital.”

Piyoosh, along with his brothers Bipin and Bharat, founded Waremoss in 1978.

He served served as the company’s finance director and helped the group grow into one of the country’s largest independent pharmacy chains.

Piyoosh oversaw the recent move of the company’s headquarters into brand new offices and warehouse.

Currently trading as Kamsons Pharmacy, the award winning chain operates over 70 pharmacies with nearly 1,000 employees.

Piyoosh’s bereaved brothers, Bipin and Bharat Chotai, commented: “The whole family is devastated by our tragic loss. The Chotai brothers all worked closely together to develop Waremoss and the Kamsons Pharmacy group.

“Piyoosh has been integral to our growth and our pharmacies are a lasting legacy to his work. We will miss him greatly. Not only did we grow up together but have worked closely together throughout our lives.”

More For You

Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Lords back amendment to exempt pharmacies from national insurance hike

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.

Keep ReadingShow less